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Introduction {#sec1}
============

The CRISPR-Cas9 system has quickly become the preferred tool for genome engineering, enabling site-specific alterations in a variety of organisms and cellular contexts ([@bib11]). The system relies on the combined use of the bacterial Cas9 endonuclease and a single-guide RNA (sgRNA) to substitute, insert, or delete DNA sequences in almost any desired location in the genome ([@bib11]). Regardless of the experimental setting and application, genome editing by the CRISPR-Cas9 system entails three steps: (1) scanning of the genome by the RNA-guided Cas9 nuclease (RGN) to find the DNA sequence complementary to the sgRNA, (2) creation of a DNA double-strand break (DSB) by Cas9, and (3) repair of the lesion by the endogenous DNA repair machinery ([@bib11]). Both the accuracy and efficiency of the processes involved in each of these steps strongly affect the outcome of CRISPR-mediated editing and consequently the utility of the technology. Since the adaptation of the CRISPR system as an engineering tool, several studies have provided insights into the mechanisms affecting CRISPR-mediated DNA editing and have improved the method ([@bib3], [@bib9], [@bib10], [@bib11], [@bib12], [@bib27], [@bib24], [@bib25]). However, fundamental questions about how the mammalian genome and proteins interact with Cas9 and the sgRNAs and how cells respond to CRISPR-induced DNA damage remain unanswered. Increasing our knowledge of the mechanisms regulating these interactions is crucial to maximize the potential and safety of CRISPR-based approaches.

A key prerequisite for a good editing tool is the ability to discriminate between on-target and homologous off-target sites. Characterization of selected sgRNAs using both *in vitro* and cellular assays has provided important information about parameters influencing RGN specificity identifying the seed region of guide RNAs (the 10- to 12-nt sequence adjacent to the protospacer adjacent motif \[PAM\] sequence) as critical for recognition of target sequences ([@bib11]). This characterization has guided sgRNA-designing algorithms and improved CRISPR fidelity. However, systematic investigation of off-target cleavage sites has shown that predicting the specificity of any given RGN is not straightforward and has revealed that our understanding of how RGNs scan the mammalian genome is incomplete ([@bib24]). Importantly, by showing that truncated guide RNAs (17--18 nt) exhibit substantially reduced off-target DSBs, this large-scale analysis has proposed modifications that can considerably improve the technology and benefit various applications ([@bib24]). This example illustrates how systematic characterization of CRISPR-induced alterations in experimental systems may provide information about how RGNs interact with complex genomes and help optimize editing outcome.

In addition to specificity, activity is another feature that can vary widely across RGNs. While direct measurement of cleavage activity at a given target is not simple, sgRNA efficacy has been inferred either by quantifying the frequency of insertion and/or deletion (indel) formation or by evaluating the ability of an sgRNA to induce an expected phenotype. Analysis of large-scale studies has revealed sequence patterns correlating with sgRNA activity and has guided refinement of algorithms for sgRNA design ([@bib6], [@bib28]). Although *in silico* predictions of sgRNA efficacy have improved considerably, concordance between predicted and empirically measured indel activity remains moderate ([@bib9]). Thus, while we have achieved a qualitative understanding of RGN activity determinants, additional parameters not included in the current algorithms likely contribute to the overall outcome. The epigenetic status of target sequences may be one such factor. Although correlative evidence and *in vitro* studies have implicated chromatin in the modulation of RGN activity ([@bib10], [@bib25]), formal demonstration that the chromatin status of an endogenous locus affects its editing potential is still lacking.

DSBs induced by RGNs at target sites are recognized by the cell's DNA damage response pathways and repaired. Failure of accurate repair creates a chance for sequence alteration. When an exogenous repair template is provided, the homologous recombination (HR) repair pathway allows introduction of precise modifications in the DNA sequence, including single point mutations or insertion of exogenous sequences ([@bib11]). In the absence of a template, RGN-induced DSBs are often repaired through relatively error-prone mechanisms that result in insertions or deletions of variable length. Indels disrupting gene open reading frames lead to production of truncated, often nonfunctional proteins, making RGN-induced editing an effective means to induce gene knockout (KO) ([@bib11]). Despite the wide use of the CRISPR system to generate KO alleles, our understanding of the mechanisms driving indel formation is still limited, making the functional outcome of genome editing unpredictable and often preventing a rational use of the technology. Based on the type of indels observed upon RGN-mediated editing, two major repair pathways have been implicated in the formation of RGN-induced indels: canonical non-homologous end joining (cNHEJ), which is known to induce small indels, and microhomology-mediated end joining (MMEJ), which typically generates larger deletions at regions of microhomology (MH) ([@bib5]). Of note, genetic studies examining the general role of these pathways in the formation of CRISPR-mediated indels are currently lacking and the predominant method of repair of RGN-induced DSBs remains unclear. Based on the assumption that NHEJ is the main pathway involved in CRISPR-mediated indel formation, repair outcome was thought to be random. However, recent characterization of indel patterns at multiple genomic locations revealed that individual targets show reproducible repair outcome, with distinct preferences for class (insertion or deletion) and size of indels ([@bib27]). This finding suggests a deterministic nature of RGN-induced break repair and raises questions about the factors involved in defining these nonrandom patterns. Here, we performed a large-scale genomic characterization of indel patterns examining over 1,000 sites in the genome of human cells, with the aim of understanding how genetic and epigenetic factors influence CRISPR-mediated DNA editing. We find that Cas9-induced DSBs are repaired in a predictable or unpredictable way, depending on the target site. Precise targets, which show a dominant indel, can be identified *in silico* and their likely repair outcome inferred by their DNA sequence. Our findings suggest that selection of a predictable target is an effective strategy to induce desired CRISPR-mediated alterations.

Results {#sec2}
=======

Large-Scale Analysis of Indel Patterns {#sec2.1}
--------------------------------------

To characterize general patterns of RGN-induced indels, we selected 1,491 target sites across the genome and retrieved the corresponding sgRNAs from a previously generated arrayed lentiviral library ([Table S1](#mmc2){ref-type="supplementary-material"}) ([@bib9]). The library targets 450 nuclear genes with multiple sgRNAs and has shown overall high activity ([@bib9]). At least three sites for each gene were selected, spacing the target regions along genes ([Figure S1](#mmc1){ref-type="supplementary-material"}A) and using sgRNAs with high predicted activity ([@bib4], [@bib6]) ([Figure S1](#mmc1){ref-type="supplementary-material"}B). Retrieved sgRNAs were combined and sequenced to confirm homogeneous representation in the resulting pools ([STAR Methods](#sec4){ref-type="sec"}) ([Figures 1](#fig1){ref-type="fig"}A and [S1](#mmc1){ref-type="supplementary-material"}C). Pooled sgRNAs were then transduced into HepG2 cells expressing Cas9 and allowed to edit their target sites for 5 days, a time frame sufficient to reach a plateau in terms of generated indels ([@bib3], [@bib27]) ([Figure S1](#mmc1){ref-type="supplementary-material"}D) but short enough to avoid KO-induced phenotypic changes that may confound the results ([Figure S1](#mmc1){ref-type="supplementary-material"}E). Upon isolation of genomic DNA, target regions were captured by pull-down using custom probes and sequenced at ∼6,000- to 8,000-fold coverage ([Figures 1](#fig1){ref-type="fig"}A, [S2](#mmc1){ref-type="supplementary-material"}A, and S2B). As expected, infection with pooled sgRNAs resulted in a high proportion of cells with unedited sequence at each target site, since only a small fraction of cells within the population expressed each sgRNA and could edit the corresponding site ([Figure S2](#mmc1){ref-type="supplementary-material"}B). Therefore, we developed a custom computational pipeline to filter reads from unedited cells for a given sgRNA, which enabled robust detection of indels ([STAR Methods](#sec4){ref-type="sec"}) ([Figure S2](#mmc1){ref-type="supplementary-material"}B). In total, 1,248 sites showed detectable indels, ranging from 1 to 188 per target, with a median count of 32 ([Figure S2](#mmc1){ref-type="supplementary-material"}C). This is a likely underestimation of induced indels, due to the limited sensitivity of our experimental approach, but it provides sufficient repair events to identify general indel patterns. Analysis of target sites in unedited control cells showed minimal indel counts, confirming robust and specific detection of on-target indels ([Figures S2](#mmc1){ref-type="supplementary-material"}C and S2D). Furthermore, high-coverage analysis of cells transduced with individual sgRNAs showed indel profiles very similar to those detected when using pooled sgRNAs ([Figure S2](#mmc1){ref-type="supplementary-material"}E). Targets with at least 10 reads containing indels (649 sites) were selected for downstream analysis.Figure 1General Specificity and Reproducibility of CRISPR-Mediated Indel Profiles(A) Overview of the experimental setup.(B) Frequency at which each detected indel occurs at each target site in two biological replicates.(C) Indel profiles for two biological replicates at the indicated target sites. Indel nomenclature: \[start coordinate relative to cleavage site\]:\[size\]\[insertion or deletion\]. Counts are normalized to the total library size for each experiment. Numbers in gray indicate indel frequency.(D) Size distribution of the commonest indel size at each target.(E) Percentage of indels resulting in a frameshift mutation at each target. Inset pie chart shows the proportion of targets for which the commonest observed indel is a frameshift mutation.(F) Heatmap visualizing the frequency at which indels of a given size occur at each target. Sites are clustered using Ward D2 hierarchical clustering. The bar plot above indicates the number of indels observed at the corresponding sites. Only data from targets from the 450 pools (524 targets) are used to enable fair comparisons.See also [Figures S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"} and [Table S1](#mmc2){ref-type="supplementary-material"}.

In agreement with previous studies that examined a limited number of sites ([@bib2], [@bib27]), we observed that RGN-induced editing was highly reproducible across biological replicates (Spearman's coefficient 0.75, p \< 2.2 × 10^−16^), indicating that repair outcome is nonrandom ([Figures 1](#fig1){ref-type="fig"}B and 1C). Validated sites confirmed these results, showing almost identical indel patterns in two independent experiments ([Figure S2](#mmc1){ref-type="supplementary-material"}F). Furthermore, our ability to probe a large number of sites simultaneously allowed us to reveal general patterns of CRISPR-mediated DNA editing and make a number of observations. First, single-nucleotide indels were the most frequent type of indel for the majority of targets, with 44% and 26% of targets showing 1-nt insertions or deletions, respectively, as their commonest indel ([Figure 1](#fig1){ref-type="fig"}D). Nevertheless, sites showing a preference for longer deletions (up to 41 nt) were also observed ([Figure 1](#fig1){ref-type="fig"}D). Second, in line with the observed bias for single-nucleotide alterations, CRISPR-induced indels often resulted in frameshift alterations ([Figure 1](#fig1){ref-type="fig"}E). On average, 80.1% of indels induced at a given site disrupted the gene coding frame, a percentage significantly higher than the theoretical 66% assuming a random outcome (p \< 2.2 × 10^−16^, χ^2^ test) ([Figure 1](#fig1){ref-type="fig"}E). Moreover, 81% of all detected indels resulted in a frameshift ([Figure 1](#fig1){ref-type="fig"}E). Thus, the probability of achieving protein loss of function through CRISPR-induced indels is typically relatively high. However, three sites showed strong preference for in-frame indels (in-frame indels ≥ 70%), suggesting that in certain cases, it may be difficult to successfully induce gene KO. Third, unsupervised hierarchical clustering identified four groups of targets showing similar indel patterns ([Figure 1](#fig1){ref-type="fig"}F). Based on the relative frequency of the observed indels, targets could be broadly divided into sites that preferentially show small insertions, small deletions, long deletions, or have no clear preference ([Figure 1](#fig1){ref-type="fig"}F). Fourth, sgRNA activity, as measured by quantifying indel counts at each site, was highly variable, ranging from 0 to 188 ([Figures S2](#mmc1){ref-type="supplementary-material"}C and [1](#fig1){ref-type="fig"}F). Indel count did not correlate with abundance of sgRNAs in the pools, suggesting that sgRNA activity is intrinsically variable ([Figure S2](#mmc1){ref-type="supplementary-material"}G). This observation is in agreement with previous findings obtained by inferring sgRNA activity from their ability to induce an expected phenotype ([@bib6], [@bib28]). Of note, several inactive sgRNAs had high predicted activity scores, indicating that predicting algorithms can be further improved and that, in addition to DNA sequence, other factors may affect sgRNA activity at a given site ([Figure S1](#mmc1){ref-type="supplementary-material"}B). Activity did not correlate with preference for a certain type of indel pattern ([Figure 1](#fig1){ref-type="fig"}F).

Precision of CRISPR-Induced DNA Editing Varies Considerably across Sites {#sec2.2}
------------------------------------------------------------------------

The observation that different targets display distinct preferences for certain indel types prompted us to examine the degree of editing precision (i.e., recurrence of a specific indel) across sites. To do so, we first calculated the relative frequency of each distinct indel, defined by its coordinates and base composition, at each site and then ranked all sites based on the frequency of the commonest indel. This analysis revealed a large range of editing precision, with some targets displaying up to 79 distinct, infrequent indels (frequency \< 5%) and others showing one dominant indel (up to 94% frequency) and only a few additional ones ([Figures 2](#fig2){ref-type="fig"}A, 2B, and [S3](#mmc1){ref-type="supplementary-material"}A). Overall, we found that for approximately one-fifth of the targets, there is at least a 50% chance of inducing a specific indel, but the majority of sites are more unpredictable. On average, the commonest indel frequency for a given site was 34.1%, and the median number of observed distinct indels was 12.Figure 2Site-Specific Precision of DNA Editing(A) Heatmap visualizing the frequency of each indel at each target. Red, commonest indel; blue, indels ranking 2--19; gray, indels ranking higher than 20. Bar plot shows the normalized number of distinct indels at each site.(B) Indel profiles of two imprecise (left) and two precise (right) targets. Indels are ordered by start coordinate relative to the cleavage site (arrowhead), with insertions having priority over deletions. The inset number indicates the total number of indels detected at that site.See also [Figure S3](#mmc1){ref-type="supplementary-material"}.

Editing Precision Correlates with Editing Efficiency, Indel Type, and Indel Size {#sec2.3}
--------------------------------------------------------------------------------

To examine the relationship between editing precision and indel features, we categorized target sites into three groups: imprecise (0 \< commonest indel frequency ≤ 0.25), middle (0.25 \< commonest indel frequency ≤ 0.5) and precise sites (0.5 \< commonest indel frequency ≤ 1), with each group containing comparable numbers of sites ([Figure 3](#fig3){ref-type="fig"}A). Notably, editing precision correlated with efficiency of indel formation (p \< 2.2 × 10^−16^, Kruskal-Wallis test) ([Figure 3](#fig3){ref-type="fig"}B). Precise targets showed on average twice as many indels as imprecise targets, and the most active sites showed a strong preference for specific indels (commonest indel frequency \> 0.57) ([Table S2](#mmc3){ref-type="supplementary-material"}). This pattern was not due to differences in sgRNA abundance or sequencing depth among groups ([Figures S3](#mmc1){ref-type="supplementary-material"}B and S3C). We then asked whether editing precision correlated with preference for insertions or deletions. Imprecise targets showed a high proportion of deletions, with insertions being on average only 20% of the total indels, whereas insertions were more frequent in the middle group of targets ([Figure 3](#fig3){ref-type="fig"}C). Precise targets segregated into two distinct subsets; 68.4% showed a strong preference for insertions, whereas the rest mainly repaired RGN-induced breaks by inducing deletions ([Figure 3](#fig3){ref-type="fig"}C). The two subsets were clearly separated, likely reflecting their tendency to induce mainly one dominant indel. Editing precision also correlated with absolute indel size ([Figure 3](#fig3){ref-type="fig"}D). While imprecise and middle targets showed a range of indel sizes, with deletions as long as 2,315 bp, precise targets displayed a strong bias toward single-nucleotide indels ([Figures 3](#fig3){ref-type="fig"}D, 3E, and [S3](#mmc1){ref-type="supplementary-material"}A). Combining insertion and deletions, 71.5% of edited sequences in the precise group had a single-nucleotide alteration. We conclude that RGN-related editing precision varies considerably across sites and correlates with editing efficiency and the type of resulting indels.Figure 3Relationship between Editing Precision and Indel Features(A) Distribution of commonest indel frequencies at target sites. The background indicates three groups of sites as defined based on their editing precision. Inset numbers indicate the number of target sites in that group.(B--D) Relationship between precision and indel count (B), type of indel (C), and indel size (D). Only data from the 450 pools are used in (B) to enable fair comparisons.(C) Percentage of indels that are insertions at each target. I, imprecise; M, middle; P, precise. Statistical analysis was done using the Kruskal-Wallis test followed by Dunn's test for multiple comparisons with Benjamini-Hochberg correction for multiple testing.(E) Relationship between the median absolute indel size and the commonest indel frequency (i.e., the measure of editing precision at each target). The background is colored as in (A).See also [Figures S3](#mmc1){ref-type="supplementary-material"} and [Table S2](#mmc3){ref-type="supplementary-material"}.

Precise Targets Exhibit Primarily Homology-Associated Insertions and Deletions {#sec2.4}
------------------------------------------------------------------------------

Although indel profiles have been shown to be dependent on both MH-dependent and MH-independent mechanisms ([@bib1], [@bib3], [@bib27]), a quantitative assessment of their relative contribution across many target sites is lacking. In the absence of genetic or pharmacological interference with specific repair pathways (e.g., NHEJ, homology directed repair \[HDR\], or MMEJ), characterization of indel profiles is insufficient to determine which specific mechanism led to an observed outcome. We therefore performed a pathway-agnostic analysis of indels that searched for any homology at the indel boundaries. This analysis revealed that MH of variable size, ranging from 1 to 18 nt, characterized the majority of deletions ([Figures 4](#fig4){ref-type="fig"}A--4C; [Table S3](#mmc4){ref-type="supplementary-material"}). 73.3% of all deletions showed evidence of MH-mediated repair (MH deletions), and on average, 74.3% of deletions at a given site were characterized by MH ([Figure 4](#fig4){ref-type="fig"}A). Deletions associated with shorter MHs (1--4 nt) were also enriched above the expected frequency, indicating that the effect of sequence homology on repair outcome is not limited to longer MH stretches (5--25 nt) used by the MHEJ pathway ([Figure 4](#fig4){ref-type="fig"}B). MH deletions were enriched in the groups of precise and middle targets (p = 1.36 × 10^−5^, Kruskal-Wallis test) ([Figure 4](#fig4){ref-type="fig"}D). Furthermore, regardless of editing precision, 80% of targets had a MH deletion as their commonest.Figure 4Precise Targets Are Enriched for Homology-Associated Indels(A) Percentage of microhomology (MH)-associated deletions at each target site. Inset pie chart shows the proportion of all detected MH deletions.(B) Percentage of deletions that have MH of a given size. The gray bar indicates the expected percentage for each *k*-mer size. Statistical analysis was done using the χ^2^ test.(C) Deletions detected at the ARID1D.7 site. In the gray panel is the reference sequence, with the PAM sequence emboldened in blue and the expected cleavage site indicated with a red line. Below, each line represents a detected deletion. In the dashed box is the MH in the deletion, and emboldened in red is the corresponding MH in the unedited part of the sequence.(D) Percentage of MH deletions at individual sites grouped by precision. I, imprecise; M, middle; P, precise. Statistical analysis was done using the Kruskal-Wallis test followed by Dunn's test for multiple comparisons with Benjamini-Hochberg correction for multiple testing.(E) Frequency of the commonest insertion at a target site. Only targets with 5 or more insertions are considered to obviate a low-count bias. The inset count is the number of target sites included.(F) Insertions detected at the indicated sites. In the gray panel is the reference sequence, with the PAM sequence emboldened in blue and the expected cleavage site indicated with a red line. The −4 position is underlined. Below, the edited sequence is shown with the insertion homology (either a mono- or dinucleotide) emboldened in red.(G) Percentage of homologous insertions at individual target sites grouped by precision. Statistical analysis was done using the Kruskal-Wallis test followed by Dunn's test for multiple comparisons with Benjamini-Hochberg correction for multiple testing.(H) Percentage of all homologous insertions in a group (filled bars) and corresponding percentage of commonest insertions (outlined bars).(I) Nucleotide inserted as the commonest insertion for each precision group.See also [Tables S3](#mmc4){ref-type="supplementary-material"} and [S4](#mmc5){ref-type="supplementary-material"}.

Although sequence homology has not been implicated in the formation of insertions, surprisingly, we found that many target sites showed recurrent insertions containing a common inserted base, suggesting that the choice of inserted nucleotide is nonrandom ([Figures 4](#fig4){ref-type="fig"}E and [S3](#mmc1){ref-type="supplementary-material"}A; [Table S4](#mmc5){ref-type="supplementary-material"}). Moreover, the recurrently inserted base was often homologous to the nucleotide at position −4 from the PAM sequence, which is typically the nucleotide upstream of the cleavage site ([@bib14]) (82% of the commonest insertions at each target) ([Figure 4](#fig4){ref-type="fig"}F); we termed this feature "insertion homology." As observed for deletions, the prevalence of insertion homology correlated with editing precision (p \< 2.6 × 10^−16^, Kruskal-Wallis test) ([Figures 4](#fig4){ref-type="fig"}G and 4H). Precise targets displayed 96% of homologous insertions, whereas this percentage was only 57% in the imprecise group (p \< 2.6 × 10^−16^, χ^2^ test) ([Figure 4](#fig4){ref-type="fig"}H), suggesting that template-mediated insertions are a strong determinant of the observed site-specific indel profiles. Even at imprecise targets, homologous insertions were often the commonest ones ([Figure 4](#fig4){ref-type="fig"}H). Notably, precise targets showed a strong bias for inserted "A"s and "T"s, suggesting that sequence features underlie the correlation between editing precision and homologous insertions ([Figure 4](#fig4){ref-type="fig"}I). Altogether, these observations suggest that homology-mediated end joining strongly influences DNA repair outcome, for both insertions and deletions, and correlates with site-specific precision of CRISPR-mediated editing.

The DNA Sequence Determines Editing Precision {#sec2.5}
---------------------------------------------

To examine whether editing precision depends on the base composition of target sites and, if so, to identify critical positions in the protospacer, we employed a machine learning approach. We trained a neural network that predicts editing precision (i.e., commonest indel frequency) using 80% of the targets selected randomly to train the network, with the remaining 20% kept unseen for testing. We found a significant correlation between the estimated and observed indel frequencies for the 130 test target sites (correlation coefficient R = 0.49, p = 4.73 × 10^−9^, Wald test) ([Figures 5](#fig5){ref-type="fig"}A and [S4](#mmc1){ref-type="supplementary-material"}A). Analysis of an independent dataset characterizing indel profiles at 96 distinct sites ([@bib27]) confirmed these findings (R = 0.53, p = 7.26 × 10^−8^) ([Figures 5](#fig5){ref-type="fig"}B and [S3](#mmc1){ref-type="supplementary-material"}E). Importantly, targets analyzed by van Overbeek et al. were selected differently from ours and showed distinct overall nucleotide composition, indicating that the neural network has learned generalizable features ([Figures S3](#mmc1){ref-type="supplementary-material"}D and [S4](#mmc1){ref-type="supplementary-material"}B). Although the predictive power of the model was only moderate (coefficient of determination R^2^ = 0.24), it allowed us to identify important positions in the protospacer. If certain positions have a significant influence on editing precision, then randomizing those nucleotides is expected to dramatically reduce the correlation between estimated and observed indel frequencies. To investigate this, we performed a permutation "nucleotide" importance analysis, systematically randomizing each position in test sequences and examining the resulting effect on the neural network output. This analysis revealed that the nucleotide at position −4 from the PAM sequence had the strongest influence on editing precision as a single nucleotide, reducing the model's accuracy by 78% ± 9% upon randomization (R^2^ = 0.05 ± 0.02) ([Figure 5](#fig5){ref-type="fig"}C). Nucleotide positions −2, −3, and −5 also showed an effect, although weaker, reducing R^2^ by 29% ± 9%, 15% ± 5%, and 50% ± 13%, respectively. Simultaneous randomization of all four nucleotides reduced R^2^ by over 98% ± 2% and abolished the predictive significance of the trained model (average R^2^ = 0.01 ± 0.01; p \> 0.1 for all permutations, Wald tests), indicating that these positions within the protospacer, especially the one upstream of the cleavage site, are critical for defining editing precision of a target site ([Figure 5](#fig5){ref-type="fig"}D). We refer to these combined nucleotides as the "precision core" of a target site. Similar results were obtained using a least absolute shrinkage and selection operator (LASSO) linear regression model ([Figures S4](#mmc1){ref-type="supplementary-material"}C and S4D).Figure 5A Neural Network Identifies Protospacer Nucleotide Positions that Determine Editing Precision(A and B) Correlation between the observed precision at a given target site and that predicted by the neural network, using our test set (A) and independent dataset ([@bib27]) (B). R, correlation coefficient. Statistical analysis was done using the Wald χ^2^ test.(C and D) Contribution of the indicated protospacer nucleotides (C) or combination of nucleotides (D) to editing precision. The effect of nucleotide randomization is shown as reduction of the model's accuracy (R^2^). Values are mean and SD from 10 different permutations. Bars in red indicate randomized positions that increased p values of Wald tests across the majority of permutations to nonsignificant levels (p \> 0.05).(E) Sequence logos for the precision core for the different precision groups. Precise targets are split based on their preference (commonest indel) for insertions or deletions. The most important −4 nucleotide position is highlighted in a yellow box.(F and G) Proportion (F) and percentage (G) of targets that have the indicated nucleotide at the −4 position. Sites are grouped based on their precision and their preference (commonest indel) for insertions or deletions.(H) Likelihood of editing outcome for sites having the indicated nucleotides at the −5 and −4 positions. Numbers represent the median commonest frequency and the insertion rate for each mono- or dinucleotide as measured in our dataset. See also [Table S5](#mmc1){ref-type="supplementary-material"}.See also [Figure S4](#mmc1){ref-type="supplementary-material"} and [Table S5](#mmc1){ref-type="supplementary-material"}.

Targets in different precision groups revealed differences in protospacer nucleotide composition ([Figures 5](#fig5){ref-type="fig"}E and [S4](#mmc1){ref-type="supplementary-material"}E). Notably, precise targets showed distinct base preferences depending on whether the commonest indel was an insertion or a deletion ([Figure 5](#fig5){ref-type="fig"}E). As expected, nucleotide −4 showed the biggest differences, followed by nucleotide −5, which was frequently a "C," specifically in precise targets ([Figure 5](#fig5){ref-type="fig"}E). We then examined to what extent nucleotide −4 on its own could predict editing outcome. Different bases at position −4 showed distinct association with indel types (insertions versus deletions) and precision groups ([Figure 5](#fig5){ref-type="fig"}F). The vast majority of target sites that contained an "A" or a "T" upstream of the cleavage site repaired RGN-induced DSBs via insertions (77% and 91% of targets, respectively) ([Figure 5](#fig5){ref-type="fig"}G). These were mostly precise or middle targets (median commonest indel frequency: 0.42 and 0.56 for targets with "A" and "T," respectively) ([Figures 5](#fig5){ref-type="fig"}G and [S4](#mmc1){ref-type="supplementary-material"}F). When taking into account positions −5 and −4 together, the correlation with precision further increased (median commonest indel frequency: 0.53 and 0.65 for targets with "CA" and "AT," respectively) ([Figure 5](#fig5){ref-type="fig"}E; [Table S5](#mmc1){ref-type="supplementary-material"}). In contrast, 79% of targets containing a "G" at position −4 showed deletions and were mostly imprecise targets (median commonest indel frequency: 0.21) ([Figures 5](#fig5){ref-type="fig"}G and [S4](#mmc1){ref-type="supplementary-material"}F). Moreover, 76.4% of targets containing "CC" at positions −5 and −4 induced relatively precise deletions (median commonest indel frequency: 0.39) ([Figure 5](#fig5){ref-type="fig"}E; [Table S5](#mmc1){ref-type="supplementary-material"}). Notably, similar distributions were observed at the sites edited by [@bib27] ([Figures S4](#mmc1){ref-type="supplementary-material"}F and S4G). Given the large number of sites examined, the observed percentages assume a predictive value with respect to the editing outcome that may occur at similar protospacers ([Figure 5](#fig5){ref-type="fig"}H). We conclude that precise targets can be identified by examining the base composition of the precision core and that position −4 is sufficient to predict with a high degree of confidence whether a site will acquire insertions or deletions.

Chromatin States Affect RGN Activity {#sec2.6}
------------------------------------

Our findings, in agreement with previous small-scale studies ([@bib2], [@bib27]), suggest that DNA sequence features strongly affect RGN-induced indel profiles in a site-specific manner, influencing editing precision and efficiency. However, even within precision groups, the number of induced indels and their patterns varied across sites ([Figure 3](#fig3){ref-type="fig"}B). Furthermore, the neural network model, based solely on the protospacer sequence, was unable to fully recapitulate observed frequencies, suggesting other factors at play. We therefore examined whether chromatin structure may contribute to the observed editing outcome. To do so, we selected six target sites characterized by variable editing precision and efficiency of indel formation ([Figure 6](#fig6){ref-type="fig"}A) and individually transduced the corresponding sgRNAs in Cas9-expressing cells in the presence of chromatin-modulating compounds. We used the histone deacetylase (HDAC) inhibitor trichostatin A (TSA) to induce histone hyperacetylation at the target sites ([Figures S5](#mmc1){ref-type="supplementary-material"}A and S5B) using concentrations of the inhibitor that do not impair cell proliferation or induce DNA damage ([Figures S5](#mmc1){ref-type="supplementary-material"}C and S5D). TSA treatment significantly increased the efficiency of indel formation, inducing dose-response changes (p \< 0.001, paired Wilcoxon test) and reaching almost a 2-fold increase for the ACTL6A.5 site ([Figure 6](#fig6){ref-type="fig"}B). The effect was highly reproducible across biological replicates ([Figures 6](#fig6){ref-type="fig"}B and 6D; [Table S6](#mmc6){ref-type="supplementary-material"}), varied depending on the target, and inversely correlated with the endogenous levels of histone acetylation ([Figures 6](#fig6){ref-type="fig"}B, 6C, and [S5](#mmc1){ref-type="supplementary-material"}B). Sites characterized by low levels of acetylated H3 showed a greater response to the treatment than those that already had high levels of the endogenous mark (MSH6.2 and SMARCD2.1), suggesting a direct effect of chromatin modulation on indel formation ([Figures 6](#fig6){ref-type="fig"}B, 6C, and [S5](#mmc1){ref-type="supplementary-material"}B). Editing efficiency was also affected, to a lower extent, by treatment of cells with EZH2i inhibitors, which decreased H3K27me3 levels ([Figure S5](#mmc1){ref-type="supplementary-material"}A). Contrary to TSA, EZH2i inhibited indel formation ([Figure 6](#fig6){ref-type="fig"}B). Analysis of individual indels indicated that the effect of TSA and EZH2i was not restricted to a few indels and that both insertions and deletions were affected ([Figures 6](#fig6){ref-type="fig"}D and [S6](#mmc1){ref-type="supplementary-material"}A; [Table S6](#mmc6){ref-type="supplementary-material"}). We conclude that the chromatin state of target sites affects the activity of RGNs and that transient induction of histone acetylation enhances DNA editing efficiency.Figure 6Chromatin Modulation Affects RGN Activity(A) Indel profile at the indicated target sites in untreated cells. Indels are ordered by start coordinate relative to the cleavage site (arrowhead), with counts normalized by the effective library size at each site. The mean across both replicates is shown.(B) Editing efficiency (above) and log~2~ fold-change in efficiency relatively to untreated cells (NT) (below) for each target site in the indicated conditions. Biological replicates are shown separately in the upper graphs and averaged in the bottom graphs.(C) Mean chromatin immunoprecipitation sequencing (ChIP-seq) signal for H3K9ac and H3K27ac and DNase-seq signal in untreated HepG2 cells ([@bib17]). Signal in a 500-nt window centered on the cleavage site at each target site is shown as a heatmap.(D) Chromatin modulation affects both insertions and deletions. Count of individual indels at the indicated sites in untreated cells (above), and log~2~ fold-change in efficiency induced by TSA or EZH2i relative to untreated cells (below). Indel count is normalized to the effective library size at each site for each replicate. Only indels with a normalized count of at least 1 in any condition are included. The indel nomenclature is \[start coordinate relative to cleavage site\]:\[size\]\[insertion or deletion\].See also [Figures S5](#mmc1){ref-type="supplementary-material"} and [S6](#mmc1){ref-type="supplementary-material"} and [Table S6](#mmc6){ref-type="supplementary-material"}.

Chromatin States Influence Indel Profiles but Do Not Alter Dominant Indels at Precise Sites {#sec2.7}
-------------------------------------------------------------------------------------------

Although changes in editing efficiency by TSA or EZH2i were observed for most indels at each site, some indels were preferentially affected ([Figure 6](#fig6){ref-type="fig"}D). Furthermore, shorter and longer indels appeared differentially altered by treatment ([Figure S6](#mmc1){ref-type="supplementary-material"}B). These observations suggest that chromatin modulation may affect indel profiles. We therefore examined the relative changes in the abundance of individual indels, focusing on the effect of TSA, which induced greater and more consistent changes in indel formation ([Figures 6](#fig6){ref-type="fig"}B and 6D). Across all sites, we observed dose-dependent changes in the relative frequency of indels, with some being favored at the expense of others ([Figures 7](#fig7){ref-type="fig"} and [S7](#mmc1){ref-type="supplementary-material"}). Although the observed changes were small in extent and the overall indel patterns were maintained, confirming robustness of the editing profiles, the most frequent indels showed reproducible and dose-dependent changes ([Figure 7](#fig7){ref-type="fig"}). At some sites (MBD3L1.6, MSH6.2, and SMARCD2.1), the preference for their commonest indel was enhanced, while at others (ACTL6A.5, ASF1B.7, and BRD2.7), it was decreased ([Figure 7](#fig7){ref-type="fig"}C). Importantly, changes induced by chromatin modulation had distinct impact on sites, depending on their editing precision; for instance, the identity of the commonest indel changed at the imprecise BRD2.7 site, whereas the dominant indel at the precise ACTL6A.5 site was not altered, despite significant changes in its frequency ([Figures 7](#fig7){ref-type="fig"}A and 7C). Thus, editing of precise targets is not substantially affected by differences in chromatin states, whereas dominant indels can vary at imprecise targets depending on chromatin state. This observation has implications for DNA editing in different cell types.Figure 7Chromatin Modulation Induces Small Changes in Indel Profiles(A) Normalized indel frequency for the indicated targets in untreated cells (gray bars) and in cells treated with 100 nM TSA (red outline). Indel nomenclature: \[start coordinate relative to cleavage site\]:\[size\]\[insertion or deletion\]. The 10 commonest indels for each site are shown.(B) Log~2~ fold change in the indel frequency for the indicated targets. The 10 commonest indels across both replicates are shown.(C) Change in frequency for the three commonest indels (ranks 1, 2, and 3) for all validated target sites. The line indicates the mean of both replicates, and the shaded area represents the mean ± 1 SD. NT, untreated cells.See also [Figures S5](#mmc1){ref-type="supplementary-material"} and [S7](#mmc1){ref-type="supplementary-material"} and [Table S6](#mmc6){ref-type="supplementary-material"}.

As a complementary approach to experimental modulation of chromatin, we analyzed the van Overbeek dataset, which examined indel profiles at 96 sites in different cell types characterized by distinct chromatin landscapes. HCT116 cells were excluded from this analysis, as their deficiency in mismatch repair may modulate indel profiles independently of chromatin differences. Embryonic kidney HEK293 cells and lymphoblastoid K562 cells displayed very similar but not identical indel profiles, indicating that these are primarily, but not entirely, determined by DNA sequence ([Figure S5](#mmc1){ref-type="supplementary-material"}E). Sites with major differences in histone acetylation levels showed different indel profiles. As observed in our dataset, some imprecise targets showed different dominant indels in the two cell lines, whereas precise sites showed conserved indel profiles ([Figure S5](#mmc1){ref-type="supplementary-material"}F). Altogether, these results show that chromatin structure contributes to the establishment of site-specific indel profiles. While the DNA sequence appears to be the major determinant of CRISPR-mediated editing outcome, the chromatin state of a given site may modulate the relative abundance of individual indels and contributes to defining the site's indel profile. Despite chromatin-mediated differences in indel profiles, precise targets display a conserved and highly reproducible editing outcome.

Discussion {#sec3}
==========

Precision of Editing Outcome {#sec3.1}
----------------------------

Although the bacterial CRISPR system has been widely adopted as the preferred genome engineering tool, our ability to predict the editing accuracy, efficacy, and outcome at specific sites is still limited. A major obstacle in defining precise genome editing rules is our incomplete understanding of how RGNs interact with eukaryotic cellular components---complex genomes containing repetitive sequences, the packaging of DNA into chromatin, and the presence of various cellular pathways that recognize and repair RGN-induced DSBs. Various studies have provided insights into some of these interactions ([@bib3], [@bib12], [@bib13], [@bib16], [@bib18], [@bib27]). However, due to the limited number of characterized target sites, discerning whether the observed patterns are general or site-specific features is not straightforward. Through systematic analysis of indel formation at over 1,000 different sites in the human genome, this study reveals general trends of CRISPR editing and provides simple rules to predict how a given target may respond to RGN-induced DSBs.

Extending the observation that indel profiles are nonrandom ([@bib27]), we find that precision of DNA editing varies considerably among sites, with some targets showing one highly preferred sequence alteration and others displaying a wide range of infrequent, yet reproducible, indels. We show that editing precision is an intrinsic feature of the target site and depends on four nucleotides located around the cleavage site within the protospacer, with the most influential position being the nucleotide at position −4 from the PAM sequence. Strikingly, the mere presence of a "T" here gives a site a 51% probability of repairing in a predictable manner and 91% chance of introducing an insertion. Our finding that editing precision is site-specific and can be predicted has important implications. Practically, knowing what editing outcome is likely to occur at a given site maximizes the chance of having a desired sequence alteration, for both clinical and research applications. Although pharmacological modulation of repair pathways alters indel profiles, the induced changes are subtle, and for many applications, the use of inhibitors may not be suitable ([@bib27], [@bib22]). Targeting a precise site would be a more effective way of steering CRISPR-mediated editing toward a desired outcome. Moreover, given the extreme reproducibility of indel patterns, the selection of a precise target combined with experimental validation in model systems could considerably increase safety in clinical applications. This is particularly relevant in light of recent studies reporting the occurrence of large on-target deletions that may have pathological consequences ([@bib16]).

Relationship between Editing Precision and Indel Type {#sec3.2}
-----------------------------------------------------

Our findings also reveal a strong correlation between editing precision and preference for repairing RGN-induced DSBs via insertions. We show that targets with "A"s or "T"s at nucleotide −4 mainly show insertions, with the commonest insertion being highly recurrent and representing on average approximately half of the indels detected at a given site ([Figure 5](#fig5){ref-type="fig"}H). DSB repair via insertions may be kinetically faster compared to other types of indel, partly explaining the higher efficiency of precise targets and the general bias toward single-nucleotide indels. Notably, recent studies have reached similar conclusions using experimental approaches complementary to ours, based on synthetic target sites ([@bib29], [@bib21], [@bib23]). The identity of the recurrent insertions can also be predicted, as the inserted nucleotide is nearly always homologous to the −4 nucleotide ([Figures 4](#fig4){ref-type="fig"}G--4I). Such predictions could, for instance, allow efficient introduction of a stop codon (TAA) when an in-frame TA dinucleotide is present at positions −5 and −4 of the targeted region. In contrast, targets with "G"s at nucleotide −4 are the most imprecise and repair mainly induces a variety of unpredictable deletions ([Figures 5](#fig5){ref-type="fig"}G and 5H). Thus, choosing target sites with "A"s or "T"s at nucleotide −4 is an effective way to induce predictable insertions at regions of interest.

Critical Role of Nucleotide −4 in Defining Site-Specific Indel Profiles {#sec3.3}
-----------------------------------------------------------------------

The key role of nucleotide −4 in influencing editing precision and preference for indel type is particularly interesting in light of recent findings that revealed flexible scissile profiles by Cas9 and generation of 5′ overhangs upstream of the canonical cleavage site due to asymmetric cleavage of the two DNA strands ([@bib22]). Notably, 5′ overhangs are mostly observed at position −4 on the non-complementary strand. These findings, together with our results, explain the prevalence of single-nucleotide insertions homologous to the −4 nucleotide, as the overhanging nucleotide can be used as a template before ends are rejoined. Thus, paradoxically, imprecision of Cas9 cleavage is the likely cause of precision in the insertion outcome. Similarly, the high frequency of single-nucleotide deletions is likely related to the asymmetric cleavage of DNA by Cas9.

Envisioning how the base composition of position −4 may influence editing precision is not straightforward. One possibility is that the nature of the 5′ overhanging nucleotide may recruit distinct proteins involved in DNA repair. Alternatively, it may affect Cas9 binding to the broken ends, and this may, in turn, affect the repair outcome. The other nucleotides in the precision core may act similarly. Structural analysis of RGNs with distinct −4 nucleotides may help shed light on this issue.

Our observation that the vast majority of detected insertions show homology, combined with the finding that NHEJ-mediated repair of CRISPR-induced DSBs is mostly error-free ([@bib8]) and that deletions generated by sgRNA pairs can be repaired with a high level of precision ([@bib22]), suggests a model whereby flexible cleavage by Cas9 influences DNA repair fidelity; when blunt ends are generated at nucleotide −3, cells repair DSBs in an error-free manner, reconstituting the original sequence, whereas indels occur mainly when asymmetric cleavage generates overhanging ends. This model may also reconcile apparently conflicting results about the fidelity of NHEJ in CRISPR-independent and CRISPR-dependent contexts ([@bib3], [@bib7], [@bib8], [@bib26], [@bib22]). Interestingly, both outcomes are useful for genome editing, as blunt ends allow precise genomic deletions and insertions of exogenous sequences, while overhanging ends enable induction of indels resulting in gene KO.

Influence of the Chromatin Environment on Site-Specific Editing Outcome {#sec3.4}
-----------------------------------------------------------------------

Although DNA sequence is a major determinant of site-specific indel profiles, we show that packaging of DNA into chromatin may affect editing efficiency and the relative frequency of indels at a given locus. We find that histone hyperacetylation and reduction of the heterochromatin-associated mark H3K27me3 induce opposite changes in editing efficiency, enhancing and inhibiting indel formation, respectively. Although the effect of TSA was observed at all tested sites, the effect was particularly pronounced at sites with low endogenous levels of histone acetylation, suggesting that transient TSA treatment may be a strategy to enhance editing efficiency at sites located in repressive chromatin environments. While our results do not unequivocally prove that local chromatin changes are responsible for the observed effects, they are in agreement with the reported correlations between sgRNA activity and open chromatin at the genome-wide levels and evidence from *in vitro* studies indicating that nucleosome positioning impairs binding of Cas9 to DNA and inhibits its activity ([@bib10], [@bib25]). In addition to interfering with Cas9 binding to a target site, chromatin may also affect its cleavage profile, favoring either blunt ends that can be precisely repaired or overhanging ends that promote the formation of indels. We also show that modulation of chromatin differentially affects individual indels at a target site and can change the identity of the commonest indel at imprecise sites ([Figure 7](#fig7){ref-type="fig"}). Notably the magnitude of changes observed upon TSA treatment, albeit small, is comparable to those observed when inhibitors of specific DNA repair pathways are used ([@bib27]). These results show that the chromatin configuration of a given site contributes to defining its indel profile. Given the established role of chromatin in DNA repair ([@bib15]) and the involvement of multiple DNA repair pathways in mediating CRISPR-induced DNA editing ([@bib20], [@bib27], [@bib22]), altered recruitment of factors involved in different pathways may underlie the observed difference upon chromatin modulation. Importantly, regardless of chromatin states, precise targets show consistent dominant indels, suggesting that editing outcome at these sites is conserved across cell types.

In summary, our findings uncover general principles guiding CRISPR-mediated DNA editing in human cells and provide guidelines for a more effective and safer use of the technology, with important implications for clinical applications. They also reveal a striking influence of the DNA sequence in dictating DSBs repair outcomes and lay the foundation for future mechanistic studies that can increase our understanding of end-joining processes in human cells.

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**Rabbit polyclonal anti-trimethyl-Histone H3 (Lys27)MilliporeCat\# 07-449; RRID: [AB_310624](nif-antibody:AB_310624){#intref0010}Mouse monoclonal anti-Ezh2 (AC22)Cell Signaling TechnologyCat\# 3147; RRID: [AB_2102420](nif-antibody:AB_2102420){#intref0015}Rabbit polyclonal anti-Histone H3 (acetyl K27)AbcamCat\# ab4729; RRID: [AB_2118291](nif-antibody:AB_2118291){#intref0020}Rabbit polyclonal anti-mouse IgG H&LAbcamCat\# ab46540; RRID: [AB_2614925](nif-antibody:AB_2614925){#intref0025}Mouse monoclonal anti-phospho-Histone H2A.X (Ser139)MilliporeCat\# 05-636; RRID: [AB_309864](nif-antibody:AB_309864){#intref0030}HRP goat anti-rabbit IgG (Peroxidase)Vector LaboratoriesCat\# PI-1000; RRID: [AB_2336198](nif-antibody:AB_2336198){#intref0035}Donkey polyclonal anti-mouse IgG AF488Thermo FisherCat\# A-21202; RRID: [AB_141607](nif-antibody:AB_141607){#intref0040}Donkey polyclonal anti-mouse IgG AF568Thermo FisherCat\# A10037; RRID: [AB_2534013](nif-antibody:AB_2534013){#intref0045}Donkey polyclonal anti-mouse IgG AF647Thermo FisherCat\# A-31571; RRID: [AB_162542](nif-antibody:AB_162542){#intref0050}Donkey polyclonal anti-rabbit IgG AF488Thermo FisherCat\# A-21206; RRID: [AB_2535792](nif-antibody:AB_2535792){#intref0055}Donkey polyclonal anti-rabbit IgG AF568Thermo FisherCat\# A10042; RRID: [AB_2534017](nif-antibody:AB_2534017){#intref0060}**Chemicals, Peptides, and Recombinant Proteins**Trichostatin ASigmaCat\# T1952GSK126 (EZH2 inhibitor)Cayman ChemicalCat\# 15415**Critical Commercial Assays**MiSeq Reagent Kit v3IlluminaCat\# MS-102-3003DNeasy Blood & Tissue KitQIAGENCat\# 69506SureSelectXT Custom 0.5-2.9Mb libraryAgilentCat\# 5190-4816QIAquick Gel Extraction KitQIAGENCat\# 28706QIAquick PCR Purification KitQIAGENCat\# 28106Herculase II Fusion DNA polymeraseAgilentCat\# 600675CellTiter 96 Aqueous One SolutionPromegaCat\# G3582**Deposited Data**Targeted DNA-seq of Human HepG2 cells following editing with CRISPR/Cas9EBI ArrayExpressArrayExpress: [E-MTAB-7095](array-express:E-MTAB-7095){#intref0065}Targeted DNA-seq of Human HepG2 cells following editing with CRISPR/Cas9 upon chromatin modulation with TSA and EZH2iEBI ArrayExpressArrayExpress: [E-MTAB-7091](array-express:E-MTAB-7091){#intref0070}**Experimental Models: Cell Lines**Human: HepG2 cellsThe Francis Crick Cell Services DepartmentN/AHuman: HEK293-T cellsThe Francis Crick Cell Services DepartmentN/A**Oligonucleotides**Primers used in this study (see [Table S7](#mmc7){ref-type="supplementary-material"})This paperN/A**Recombinant DNA**pLenti_BSD_sgRNA[@bib9]N/A**Software and Algorithms**FastQC<https://www.bioinformatics.babraham.ac.uk/projects/fastqc/>N/ABBMap 36.59<https://sourceforge.net/projects/bbmap/>N/AR 3.3.2 - 3.4.4The R Project for Statistical Computing<https://www.r-project.org/>CrispRVariants<https://github.com/HLindsay/CrispRVariants>N/APython 3.7Python Software Foundation<https://www.python.org/>Apache MXNet (v1.2.0) (python 3 API)The Apache Software Foundation<https://mxnet.apache.org/>Custom analysis scriptsThis paper<https://github.com/luslab/crispr-indels>**Other**[@bib27]Sequence Read ArchiveSRP076796HepG2 H3K9ac, H3K27ac ChIP-seq and DNase-seq[@bib17]<http://www.roadmapepigenomics.org/>HEK293 K3K9ac ChIP-seqCistrome DB58997HEK293 K3K27ac ChIP-seqCistrome DB43073HEK293 DNase-seqGene Expression OmnibusGSM1635901-6K562 K3K9ac ChIP-seqCistrome DB45406K562 K3K27ac ChIP-seqCistrome DB55731K562 DNase-seqCistrome DB45020 & 45021

Contact for Reagent and Resource Sharing {#sec4.2}
----------------------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Paola Scaffidi (<paola.scaffidi@crick.ac.uk>).

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

### Cell lines {#sec4.3.1}

HepG2 cells, of male origin, were cultured in Minimum Essential Media (MEM) with 10% FBS, and HEK-293T cells, of likely female origin, were cultured in Dulbecco's Modified Eagle's Medium (DMEM) with 10% FBS. All media was supplemented with 2mM L-glutamine, 100U/mL penicillin, and 100 μg/mL streptomycin. All cell lines were maintained at 37°C and 5% CO~2~. Cas9-expressing HepG2 cells were generated as previously described ([@bib9]). For all experiments, Cas9 expression was induced with 1 μg/mL doxycycline 1 day prior to infection with the sgRNAs and sustained until cells were harvested for genomic DNA extraction (QIAGEN). All cell lines were obtained from the Francis Crick Institute Cell Services Department and have been STR authenticated and tested negative for mycoplasma.

Method Details {#sec4.4}
--------------

### sgRNAs pool generation {#sec4.4.1}

sgRNA pools were generated by combining equal volumes of saturated bacterial culture from the arrayed library described in [@bib9], and extracting the resulting plasmid libraries. Six different pools were generated and independently transduced into HepG2 Cas9-expressing cells. This was necessary to reduce the library complexity and allow efficient detection of indels despite the high number of unedited sequences in the cell population -- each sgRNA only infected a limited number of cells. We first tested three pools targeting 100 sites each (pools 100_1, 100_2 and 100_3). Once we confirmed efficient indel detection, we generated three sgRNA pools targeting 450 sites each (pools 450_5, 450_6, 450_7). 450 pools contained three distinct sgRNAs targeting the same 450 genes. 100 pools mainly contained sgRNAs present in the 450 pools with a few additional ones ([Table S1](#mmc2){ref-type="supplementary-material"}). Although pools were transduced and processed independently, indel analysis was performed integrating data from the different pools. When assessing efficiency of indel formation, only data from 450 pools were used. This was done because indel counts for sgRNAs present in both 450 and 100 pools were artificially higher than those detected at sites targeted only with the 450 pools. When assessing editing precision, data from both 100 and 450 pools was combined, as frequencies of individual indels are not affected by differences in indel counts.

### Viral transductions {#sec4.4.2}

Transduction of sgRNAs was performed using high titer virus, at an estimated MOI of at least 10, to increase the fraction of edited cells in the population for each sgRNA. To produce virus, 80% confluent HEK293T cells were transfected with the sgRNA pools (pLenti_BSD_sgRNA plasmids), packaging plasmids (psPax2 and pMD2G) and pAdVantage at a ratio of 3:1 DNA to FugeneHD (Promega). 24h after transfection viral particles were collected, filtered through a 0.45 μm filter and used to infect Cas9-expressing HepG2 cells in the presence of 5μg/ml Polybrene (Santa Cruz). To increase infection efficiency, plated cells were spun for 2h at 2000rpm soon after the virus-containing supernatant was added. A second infection was carried out using viral particles collected 48h after transfection. Cells were not spun for the second infection. Transduced cells were selected with 4 μg/mL blasticidin (Merck), starting 24h after the first infection, and genomic DNA was extracted 5 days after infection (QIAGEN).

### Timing of CRISPR-mediated editing {#sec4.4.3}

In order to experimentally determine the kinetics of indel formation, sgRNAs targeting 3 sites (ACTL6A.5, ASF1B.7 and SMARCD2.1) were individually transduced into Cas9-expressing HepG2 cells, using high titer virus to ensure efficient infection of all cells. Genomic DNA was isolated from infected cells (QIAGEN) for 5 consecutive days and editing of the target sites quantified by Sanger sequencing (Herculase II Fusion, Agilent) and TIDE analysis (<https://tide.deskgen.com/>) (See [Table S7](#mmc7){ref-type="supplementary-material"} for primers). To confirm the absence of possible phenotypic consequences induced by gene knock-out after 5 days, which may confound the results, cells infected with an EZH2-targeting sgRNA were analyzed by immunofluorescence to quantify the levels of both EZH2 and its associated mark H3K27me3. Based on these experiments, 5 days post-infection was concluded to be the optimal length for performing all subsequent experiments.

### Protein detection {#sec4.4.4}

Western blot analysis and immunofluorescence microscopy were performed using anti-H3K27ac (Abcam ab4729), anti-H3K27me3 (Millipore 07-449), anti-ɣH2A.X (Millipore 05-636), anti-EZH2 (CST 3147) and Alexa Fluor- or HRP-conjugated secondary antibodies following standard protocols.

### Chromatin modulation and ChIP-qPCR {#sec4.4.5}

To investigate the effect of chromatin on CRISPR-mediated DNA editing, HepG2 cells were treated with the HDAC inhibitor Trichostatin A (Sigma), which induces histone hyperacetylation, and the EZH2 inhibitor GSK126 (Cayman Chemical), which globally reduces H3K27me3 levels. Cells pre-treated with TSA (11nM or 100nM) or GSK126 (0.3μM and 3μM) for 5 days were infected with sgRNAs targeting the ACTL6A.5, ASF1B.7, BRD2.7, MBD3L1.6, MSH6.2 and SMARCD2.1 sites. Treatment was continued for an additional 5 days while indels were induced. Compounds were refreshed daily over the course of the experiment. Successful alteration of histone acetylation at the target sites was confirmed by ChIP-qPCR of H3K27ac in cells either untreated (NT) or treated with TSA (100nM). For both conditions, 8 million HepG2 cells were fixed with 1% formaldehyde for 10 min at room temperature, treated with 125mM glycine for 5min at RT, washed three times with ice-cold PBS and scraped off cell culture plates in PBS supplemented with 10% FBS. Cell pellets were resuspended in 0.6mL of IP buffer (1:1 of SDS buffer (0.5% SDS, 0.2% NaN~3~, 5mM EDTA pH 8, 50mM TRIS pH 8, 100mM NaCl): Triton buffer (5% Triton X, 0.2% NaN~3~, 5mM EDTA pH 8, 100mM NaCl, 100mM TRIS pH 8)) supplemented with protease inhibitors (1:100, Cell Signaling Technology) and incubated for 15 min on ice. Chromatin was subsequently sheared to 200-500bp with 2 cycles of 30sec ON/OFF using the Bioruptor sonicator (Diagenode). Chromatin from each biological replicate was divided into 2 and 200μg of sample were incubated overnight at 4°C with 8μg of either anti-acetyl H3K27 (Abcam ab4729) or control anti-rabbit IgG (Abcam ab46540). In all cases, 10% of each sample was kept as input. Next, 30μL of Pierce Protein G magnetic beads (Invitrogen) were added per sample and incubated an additional 4h at 4°C. All samples were then washed 3x with low salt wash buffer (1% Triton X, 0.1% SDS, 2mM EDTA pH 8, 20mM TRIS pH 8, 150mM NaCl) and 1x with high salt wash buffer (1% Triton X, 0.1% SDS, 2mM EDTA pH 8, 20mM TRIS pH 8, 500mM NaCl) with the use of a magnetic rack. Subsequently, 120μL of decrosslinking buffer (1% SDS, 100mM NaHC0~3~) was added to all samples and inputs and incubated overnight at 65°C. All decrosslinked samples were purified using the QIAquick PCR purification kit (QIAGEN) and eluted in 45μL of Nuclease-free water. ChIP samples were analyzed on a CFX96 real-time PCR detection system (Bio-rad) using SsoAdvanced Universal SYBR Green Supermix (Bio-rad). All samples were run in triplicates and normalized to the 10% input that was retained before pulldown.

### Cell proliferation {#sec4.4.6}

To examine the effect of the chromatin-modulating compounds on HepG2 cell proliferation, 8,000 HepG2 cells were plated per well of a 96-well plate and treated with TSA (11nM or 100nM) or GSK126 (0.3μM or 3μM) for 5 days. On a daily basis, 20μL of Cell-Titer 96 Aqueous One Solution (Promega) were added per well in triplicates and following incubation at 37°C for 1h, the Optical Density of each well was read at 490nm as a measure of the number of cells per well. The growth rate of the cells was normalized to the number of cells on day 1.

### Library preparation and deep sequencing {#sec4.4.7}

#### sgRNA representation in pools {#sec4.4.7.1}

To assess the representation of individual sgRNAs in the plasmid library, amplicons containing the sgRNA sequences were generated as previously described ([@bib9]). Briefly, PCR amplicons containing the P5 and P7 Illumina adaptors were generated using the high-fidelity Herculase II polymerase kit (Agilent), and the resulting products extracted from an agarose gel (QIAGEN). Purified products were sequenced with either a HiSeq 2500 or a MiSeq using custom sequencing and indexing primers (SeqP and IndexP, [Table S7](#mmc7){ref-type="supplementary-material"}). Following sample demultiplexing, all sgRNA sequences were trimmed and aligned to the target sequences to assess sgRNA representation (normalized read count).

#### Large scale indel sequencing {#sec4.4.7.2}

To identify CRISPR-mediated editing at targeted regions, DNA libraries enriched for the targeted sites were generated using the SureSelect Target enrichment kit (Agilent) following the manufacturer's instructions. Capture probes were designed to cover 2Kb regions centered on each target site. When multiple target sites were located in the same exon, the 2Kb region was centered on the exon middle point. Probe tiling parameters were: Tiling density: 1x; Masking: Least Stringent; Boosting: Maximize Performance. All samples were sequenced using Paired End 100bp runs on a HiSeq 4000 sequencer, multiplexing 2 samples per lane. Approximately 200 million reads were obtained for each sample. Analysis of sequenced regions confirmed good enrichment of the targeted regions ([Figure S2](#mmc1){ref-type="supplementary-material"}A).

#### Small scale indel sequencing {#sec4.4.7.3}

For validation experiments and experiments assessing the effect of chromatin modulation, indels induced at 6 selected sites were examined. In these experiments, a two-step PCR was performed on biological duplicates to generate a library of PCR amplicons. For the first PCR, 150ng of the corresponding gDNA were amplified for 20-22 cycles using the Herculase II polymerase kit yielding products of ∼500bp (See [Table S7](#mmc7){ref-type="supplementary-material"} for primers). Next, PCR products were purified as per manufacturer's instructions (QIAGEN) and 1μl of the resulting product was used as a template for the second nested PCR reaction in which primers containing barcodes and adapters for the sequencing reaction were added. Overall, a library of 60 individually barcoded amplicons of ∼300bp was generated (See [Table S7](#mmc7){ref-type="supplementary-material"} for primers). Samples were purified in a 96-well format (Zymo Research) and sequenced on a 300bp paired-end run on a MiSeq using standard Illumina sequencing primers (See [Table S7](#mmc7){ref-type="supplementary-material"} for primers). The long 300bp reads allowed assessment of both long and short indels.

### Sequencing read alignment {#sec4.4.8}

The quality of the sequenced reads was assured using FastQC. For alignment, we used BBMap (v. 36.59) as it is a global aligner that is able to align longer indels. Alignment was carried out against the UCSC hg19/GRCh37 genome assembly.

### Indel identification {#sec4.4.9}

#### Large scale indel sequencing {#sec4.4.9.1}

In order to robustly identify the reads that contained indels we adopted a two-stage alignment strategy. In the first phase we aligned the reads to the genome disallowing any reads that contained indels. We discarded reads that aligned in a proper pair in this phase and took the remainder forward. In the second phase we aligned the remaining reads to the genome, this time setting a soft threshold allowing indels up to 2000bp. Duplicates were marked using Picard (v. 2.1.0). Reads that were marked as duplicates, or that had a mapping quality score of less than 38 were filtered using samtools (v. 1.2) and sambamba (v. 0.6.0). This two-phase approach was necessary to delineate, for a given target amplicon, between reads from cells uninfected with the corresponding sgRNA and reads from cells with successful transfections, on account of the pooling of sgRNAs. For a given amplicon, only a small proportion of the total number of cells would have been transfected with the sgRNA targeting the site contained within it. We know that aligned reads containing indels arise from appropriately transfected cells. However, our approach forces the aligner to choose an alignment with no indels over one with indels for the multiple possibilities for a given read. With this approach we can improve our confidence that the reads with indels are not background noise or alignment errors. Because of the experimental approach, the sensitivity of our method is inherently limited, and it is likely that indels occurring at low frequency are not detected. Furthermore, kinetically slow repair events may be underrepresented in our dataset. Nevertheless, the observation that most targets are identified as imprecise or middle indicates that there is no significant bias toward most frequent indels. Furthermore, complementary studies using alternative experimental approaches ([@bib21]) observed a very similar distribution of precision groups, confirming the reliability of our method.

Indel identification was performed in R (v. 3.4.4) using custom scripts. The location and size of indels in reads were identified from the CIGAR string. Indels were only considered valid if they occurred within 5 nucleotides of the Cas9 cleavage site (defined as 6 nucleotides upstream of the end of the guide RNA including the PAM sequence). Any indels that could also be detected in the control HepG2 sample were removed as probable somatic mutations in this cancer cell line. To ensure robust estimate of indel frequencies, we filtered out target sites that had a low overall indel count (indels identified in fewer than 10 reads in total across all samples and replicates, where present).

#### Assessment of indel identification approach {#sec4.4.9.2}

To assess possible confounding effects from sequencing errors, particularly given the depth of sequencing, we performed two complementary analyses. First, we assessed the number of indels detected at each target site (within 5 nucleotides of the Cas9 cleavage site) in the wild-type sample without Cas9 induction and sgRNA transduction (without filtering for probable HepG2 somatic mutations). Second, we leveraged the fact that all targeted regions in the whole library were pulled down and sequenced to a similar depth in all experiments, irrespective of whether they were targeted in that particular pool or not. Therefore we compared the number of indels in both replicates from the 450 pool experiments at each target site in the experiment where the corresponding sgRNA was in the transfected pool, with the mean of the number of indels in both replicates from the two other 450 pool experiments where the corresponding sgRNA was not. This provided an estimate of the occurrence of sequencing errors in our experimental setup within 5 nucleotides of the Cas9 cleavage site.

#### Small scale indel sequencing {#sec4.4.9.3}

Before alignment, paired end reads were merged using BBMerge (v. 36.59). After alignment, duplicates were marked using Picard (v. 2.1.0). Reads that were marked as duplicates, or that had a mapping quality score of less than 38 were filtered using samtools (v. 1.2) and sambamba (v. 0.6.0). The R package CrispRVariants ([@bib19]) was used to identify indels.

### Characterization of target sites {#sec4.4.10}

Throughout, we used all detected indels from both 100 and 450 pools to characterize the targets, except when assessing for efficiency where indels from the 450 pools only were used to ensure an unbiased analysis of each target site as explained above.

#### Frameshifts and indel size {#sec4.4.10.1}

Indels were assessed for their frameshift potential by the divisibility of their size by 3. To identify patterns in the indel size profiles at target sites, we calculated the frequency of each size of indel (considered in bins of insertions greater than 1 nucleotide, insertions of 1, and deletions of 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 and greater than 10). We performed unsupervised hierarchical clustering using the Ward D2 method to categorize groups of target sites based on their indel size profiles.

#### Precision {#sec4.4.10.2}

We also categorized target sites by calculating the frequency of each distinct indel at each target site. The most frequent indel was termed the commonest; ties were broken by prioritizing insertions over deletions, and then by longest deletion. The precision of indel generation at a target site was defined based on the frequency of the commonest indel: imprecise ≤ 0.25, 0.25 \< middle ≤ 0.5, precise \> 0.5.

#### Sequence homology {#sec4.4.10.3}

The presence of MH of *n* nucleotides was assessed in the deletions. The 5′ *n* nucleotides of the deleted sequence were compared with the first *n* nucleotides downstream of the 3′ join. Likewise, the 3′ *n* nucleotides of the deleted sequence were compared with the last *n* nucleotides upstream of the 5′ join. If there was a match, this was considered as MH. For each deletion sequence, values of *n* ranging from 1 to 50 (or the length of the deletion, whichever was shortest) were used. The largest matching *n* was considered the size of the MH.

Insertion homology was assessed by extracting the inserted nucleotide from the read sequence using the CIGAR string. This was compared with the nucleotide in the −4 position of the protospacer to assess for matches. When assessing the commonest insertion, we only considered target sites that had 5 or more insertions. Where the inserted nucleotide either creates, or lies within a short repetitive stretch; e.g., "A" inserted adjacent to "A" creating "AA," or "T" inserted adjacent to/within "TT" creating "TTT"; it is not possible to identify precisely which of these nucleotides is the inserted position. The aligner arbitrarily assigns the first position to the inserted nucleotide.

### Analysis of van Overbeek data {#sec4.4.11}

For the van Overbeek 'spacer' target sites, aligned BAM files were obtained from the Sequence Read Archive for all time points in HCT116, HepG2 and K562 cell lines. Indel identification was performed in R (v. 3.4.4) using custom scripts. The location and size of indels in reads were identified from the CIGAR string. Indels were only considered valid if they occurred within 5 nucleotides of the Cas9 cleavage site (defined as 6 nucleotides upstream of the end of the guide RNA including the PAM sequence). For a given time point and cell type, indels that occurred with \< 1% frequency were filtered, as were sites that had \< 10% editing efficiency. Downstream analyses were performed as detailed in '[Characterization of target sites](#sec4.4.10){ref-type="sec"}' above.

### Indel profiles upon chromatin modulation {#sec4.4.12}

Mutation efficiency was assessed using the mutationEfficiency function from CrispRVariants ([@bib19]), considering single nucleotide variants as non-variants. To compare the counts of indels across the different conditions, in order to assess the contribution of each indel to the changes in efficiency, the raw counts for each indel in each condition were normalized to the library size for that condition. Indels that constituted less than 1% of the library size in any condition were filtered out.

To assess the effects of chromatin modulation on the indel profile of target, over and above the effects on efficiency, we performed a different normalization on the raw counts. We divided by a size factor (the total number of indels detected in a condition). In this way, we could compare the relative contribution of each indel to the overall indel profile across the different conditions. After normalization, only the most frequent 10 indels in the untreated condition were used.

### Analysis of chromatin environment {#sec4.4.13}

DNase-seq and H3K9ac and H3K27ac ChIP-seq fold-enrichment data for in HepG2 cells were obtained pre-processed from the Roadmap Epigenomics consortium ([@bib17]). We calculated the mean fold-enrichment signal in a 500bp window centered on the cleavage site of the six validation targets. For the van Overbeek 'spacer' target sites, preprocessed coverage files were obtained for DNase-seq, H3K9ac and H3K27ac ChIP-seq for HEK293 and K562 cell lines aligned to GRCh38 from sources indicated in the Key Resources table. Data quality was assessed using Cistrome's tools and manual inspection. 500bp windows centered on the cleavage site were created and converted from GRCh37 to GRCh38 using the UCSC liftOver tool. The signal in each window was extracted using Deeptools. For visualization, the mean signal for each dataset was centered and scaled across all the target sites.

### Analysis of nucleotide influence {#sec4.4.14}

#### Artificial neural network {#sec4.4.14.1}

To estimate editing precision, we designed an artificial neural network (ANN) that uses the raw sgRNA sequences as input: 20 individual nucleotides, plus the PAM sequence (as a rudimentary internal control). All variable nucleotides were encoded using one hot encoding. The input layer of the network therefore has 86 nodes, with each of the 21 variable nucleotide positions in the 23nt sgRNA target sequence represented by 4 binary inputs, and the 2 constant 'G's in the PAM sequence represented as single constant values. These are followed by a single hidden layer containing 512 neurons using rectified linear unit (ReLU) activation functions, connected to a single output node, followed by a softplus activation function. Our loss function was mean square error (L2 norm loss). The model parameters were initialized using Xavier initialization. In summary, the weights were initially filled with random numbers \[-*c*, *c*\] where:$$C = \sqrt{\frac{2.24}{0.5\  \times \left( {n_{in} + n_{out}} \right)}}$$Here, *n*~*in*~ is the number of neurons preceding weights and *n*~*out*~ is the number of neurons proceeding weights. 80% (n = 519) of our sgRNAs were randomly selected for use as a training set, with 20% (n = 130) held out as a test set. To ensure consistency and to mitigate bias introduced by particular sets of sgRNAs in the training set, we validated our model by performing bootstrapping with replacement (taking a random sample of 80% (n = 415) of our training sgRNAs each time) before training the final model (final validation RMSE = 0.15 ± 0.003). The final ANN was trained for 800 epochs using stochastic gradient descent with Nesterov momentum set to 0.9, a learning rate of 0.001, and a batch size of 100. The final model's RMSE was 0.14 for the train set, 0.18 for the test set, and 0.16 for van Overbeek et al. To identify key sequence positions with the greatest influence on editing precision, we conducted a permutation nucleotide importance analysis by systematically randomizing each nucleotide in the test set at the respective position. We maintained the original prior-distribution by shuffling the column values before one hot encoding. The mean decrease in accuracy was recorded as the reduction in R^2^ from predictions made with the unaltered sequences. We also recorded the difference in predictive statistical significance (Wald test p values). We performed the nucleotide randomization 10 times and report the average percentage reduction in R^2^ for neutralized positions. We considered an average increase in Wald test p values to \> 0.05 as having abolished the predictive significance of the model. The ANN was built, trained, and deployed using *Apache MXNET* (python 3 API) v. 1.2.0.

#### LASSO multi-regression model {#sec4.4.14.2}

To corroborate the results of our non-linear ANN model, and obtain the coefficients of the most important linear correlations with observed indel frequencies, we constructed a linear model optimized for generalization using L~1~ regularization by deploying a least absolute shrinkage and selection operator (LASSO) algorithm. Here the aim is to minimize the objective function:$$\left. \frac{1}{2n_{samples}} \right\|\left. {Xw - y} \right\|_{2}^{2} + \left. \alpha \right\|\left. w \right\|_{1}\ $$Where regularization parameter α is a constant and $\left\| w \right\|_{1}$is the L~1~ regularized parameter coefficient vector. Our training set was 80% of our data (n = 519) selected at random, with 20% (n = 130) held out to test the model. The coefficients were fitted using coordinate descent and the regularization parameter α (0.002592943797404667) selected by 10-fold cross validation on the training set. The final model's RMSE was 0.15 for the train set, 0.17 for the test set, and 0.15 for van Overbeek et al. The LASSO was built, trained, and deployed using *scikit-learn v. 0.19.1* for python 3.

Quantification and Statistical Analysis {#sec4.5}
---------------------------------------

Non-parametric statistical tests were used as appropriate and p-values were adjusted for multiple testing where necessary. Each specific test is indicated in the main text or figure legend, as well as the exact value of N and what N represents. In boxplots, the bottom and top of boxes indicate the 25th and 75th percentiles, respectively, and middle lines indicate medians. Whiskers indicate the lowest and highest data points within 1.5 × interquartile range from the box. A significance level of 0.05 was used throughout.

Data and Software Availability {#sec4.6}
------------------------------

The accession numbers for the sequencing data generated in this study are EBI ArrayExpress: E-MTAB-7091, E-MTAB-7095. Custom scripts are available at <https://github.com/luslab/crispr-indels>.
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